<p>Part 2 of our series dives deeper into the explosion of ADC clinical drug development in China</p>

Episode 409: AUA 2025 - CREST - BCG +/- Sasanlimab in high-risk NMIBC

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London